ZetrOZ系统通过运动员伙伴关系和临床支持的伤员康复运动,在2025年扩大了使用经林业发展局清除的可磨损超声波装置的机会。 ZetrOZ Systems expanded access to its FDA-cleared sam® wearable ultrasound device in 2025 through athlete partnerships and clinical-backed injury recovery campaigns.

2025年,ZetrOZ Systems通过与运动员和奥运竞争对手Ashley Hoffman和美国陆军退伍军人Noah Galloway等公众人物建立伙伴关系,扩大了使用经林业发展局批准的可磨损超声波装置的通道,后者将减轻疼痛和康复功劳归功于他们。 In 2025, ZetrOZ Systems expanded access to its FDA-cleared sam® wearable ultrasound device through partnerships with athletes and public figures like Olympic competitor Ashley Hoffman and U.S. Army veteran Noah Galloway, who credited it with pain relief and recovery. 该公司与Lnup一起发起了“ROad to Pro”运动,在MLB春季培训期间提倡预防伤害,并聘请体育教练参加“恢复侧线挑战”。 The company launched the 'Road to Pro' campaign with Lnup, promoted injury prevention during MLB Spring Training, and engaged athletic trainers in the Recovery Sideline Challenge. 超过30项临床研究支持该装置在改善行动能力和缩短肌肉骨骼损伤恢复时间方面的效力。 Over 30 clinical studies support the device’s effectiveness in improving mobility and reducing recovery time for musculoskeletal injuries. ZetrOZ在主要的医疗和体育培训会议上介绍了研究结果,并获得了关节炎基金会的“使用方便证书”。 ZetrOZ presented findings at major medical and athletic training conferences and earned the Arthritis Foundation’s Ease of Use® Certification. 萨姆X1和2.0设备利用持续的声学医学,为慢性疼痛、骨髓炎和外科后愈合等疾病提供非侵入性、无毒品治疗。 The sam® X1 and 2.0 devices, using sustained acoustic medicine, offer non-invasive, drug-free treatment for conditions like chronic pain, osteoarthritis, and post-surgical healing.